These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1066 related articles for article (PubMed ID: 33503010)

  • 61. Compatibility of heparin sodium and morphine sulfate.
    Baker DE; Yost GS; Craig VL; Campbell RK
    Am J Hosp Pharm; 1985 Jun; 42(6):1352-5. PubMed ID: 4014252
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: stability with common intravenous fluids.
    Gardella LA; Zaroslinski JF; Possley LH
    Am J Hosp Pharm; 1975 Jun; 32(6):575-8. PubMed ID: 239594
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
    Foushee JA; Meredith P; Fox LM; Wilder AG
    Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Compatibility of amifostine with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 Oct; 52(20):2208-12. PubMed ID: 8564592
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation.
    Macias JM; Martin WJ; Lloyd CW
    Am J Hosp Pharm; 1985 May; 42(5):1087-94. PubMed ID: 3923832
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
    Bougouin C; Thelcide C; Crespin-Maillard F; Maillard C; Kinowski JM; Favier M
    Am J Health Syst Pharm; 2005 Oct; 62(19):2001-5. PubMed ID: 16174836
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
    Holt RJ; Siegert SW; Krishna A
    J Pediatr Pharmacol Ther; 2008 Jul; 13(3):156-61. PubMed ID: 23055876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stability and compatibility of cimetidine hydrochloride and aminophylline in dextrose 5% in water injection.
    Baptista RJ; Mitrano FP
    Drug Intell Clin Pharm; 1988; 22(7-8):592-3. PubMed ID: 3416746
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):76-82. PubMed ID: 28346200
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF; Gilbert DL
    Am J Health Syst Pharm; 1997 Aug; 54(15):1735-41. PubMed ID: 9262747
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
    Perentesis GP; Piltz GW; Kirshcenbaum HL; Navalakha P; Aronoff W; Cutie AJ
    Am J Hosp Pharm; 1983 Jun; 40(6):1010-2. PubMed ID: 6869385
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1996 May; 53(9):1041-5. PubMed ID: 8744467
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
    De Basagoiti A; Katsumiti A; Abascal S; Bustinza A; López-Giménez LR; Pascual P; De Miguel M; Campino A
    Eur J Pediatr; 2021 Apr; 180(4):1169-1176. PubMed ID: 33128625
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
    Campbell S; Nolan PE; Bliss M; Wood R; Mayersohn M
    Am J Hosp Pharm; 1986 Apr; 43(4):917-21. PubMed ID: 3706337
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Compatibility of Lactated Ringer's Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
    Vallée M; Barthélémy I; Friciu M; Pelletier É; Forest JM; Benoit F; Leclair G
    Hosp Pharm; 2021 Aug; 56(4):228-234. PubMed ID: 34381254
    [No Abstract]   [Full Text] [Related]  

  • 80. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.